Covered stenting and transcatheter embolization of splenic artery aneurysms in diabetic patients: A review of endovascular treatment of visceral artery aneurysms in the current era

Pharmacol Res. 2018 Sep:135:127-135. doi: 10.1016/j.phrs.2018.07.023. Epub 2018 Jul 25.

Abstract

Diabetes mellitus is associated with both microvascular and macrovascular complications, which can result in visceral aneurysms as for example splenic artery aneurysms: in their management, an endovascular treatment, less invasive than surgery, is generally preferred. Endovascular treatment of splenic artery aneurysms can be based either on covered stenting (CS) or transcatheter embolization (TE). CS generally allows aneurysm exclusion with vessel preservation, while TE usually determines target artery occlusion with potential risk of distal ischemia. We performed a review of the existing literature on endovascular treatment of visceral artery aneurysms (VAAs) and psudoaneurysms (VAPAs) in the current era.

Keywords: Covered stent; Diabetes; Endovascular treatment; Transcatheter embolization; Visceral aneurysm.

Publication types

  • Review

MeSH terms

  • Aneurysm / diagnostic imaging
  • Aneurysm / therapy*
  • Diabetes Mellitus / diagnostic imaging
  • Diabetes Mellitus / therapy*
  • Embolization, Therapeutic*
  • Humans
  • Splenic Artery*
  • Stents*